Back
Alnylam Pharmaceuticals Vs. Summit Midstream Industry Stock Comparison
Sell
22
ALNY
Alnylam Pharmaceuticals
Last Price:
$237.59
Seasonality Move:
8.79%
Sell
22
SMC
Summit Midstream
Last Price:
$26.40
Seasonality Move:
16.59%
Sell
22
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $226.28. The Score for ALNY is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Summit Midstream (SMC)
is a Sell
Is Summit Midstream a Buy, Sell or Hold?
-
The current Summit Midstream [SMC] share price is $27.09. The Score for SMC is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
SMC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $226.28Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight buying pressure.
SMC Stock Price Chart
What is Summit Midstream's stock price today?
-
The Summit Midstream share price today is $27.09Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMC is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.58 | Sell |
Relative Strength Index (14 RSI): | 39.48 | Sell |
Chaikin Money Flow: | 198834 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (236.3 - 271.12) | Sell |
Bollinger Bands (100): | (238.38 - 267.68) | Sell |
SMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.08 | Sell |
Relative Strength Index (14 RSI): | 30.26 | Sell |
Chaikin Money Flow: | -89623 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.89 - 38.57) | Sell |
Bollinger Bands (100): | (34.3 - 42.12) | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 243.41 | Sell |
20-day SMA: | 256.36 | Sell |
50-day SMA: | 257.24 | Sell |
200-day SMA: | 258.01 | Sell |
8-day EMA: | 241.53 | Sell |
20-day EMA: | 250.36 | Sell |
50-day EMA: | 253.97 | Sell |
200-day EMA: | 244.7 | Sell |
SMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.19 | Sell |
20-day SMA: | 33.88 | Sell |
50-day SMA: | 38.83 | Sell |
200-day SMA: | 37.04 | Sell |
8-day EMA: | 29.75 | Sell |
20-day EMA: | 33.06 | Sell |
50-day EMA: | 36.41 | Sell |
200-day EMA: | 35.61 | Sell |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $1.34 per share, an increase this year of $1.07 per share, and an increase next year of $2.82 per share.
Summit Midstream Earnings Growth & SMC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Midstream Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |